Abstract:Abstract Background Ornithine transcarbamylase deficiency (OTCD) is most common among urea cycle disorders (UCDs), defined by defects in enzymes associated with ureagenesis. Corticosteroid administration to UCD patients, including OTCD patients, is suggested to be avoided, as it may induce life-threatening hyperammonemia. The mechanism has been considered nitrogen overload due to the catabolic effect of corticosteroids; however, the pathophysiological process is unclear. Methods To elucidate the mechanism of hyperammonemia induced by corticosteroid administration in OTCD patients, we analyzed a mouse model by administering corticosteroids to OTC spf−ash mice deficient in the OTC gene. Dexamethasone (DEX; 20 mg/kg) was administered to the OTC spf−ash and wild-type (WT) mice at 0 and 24 h, and the serum ammonia concentrations, the levels of the hepatic metabolites, and the gene expressions related with ammonia metabolism in the livers and muscles were analyzed. Results The ammonia levels in Otc spf−ash mice that were administered DEX tended to increase at 24 h and increased significantly at 48 h. The metabolomic analysis showed that the levels of citrulline, arginine, and ornithine did not differ significantly between Otc spf−ash mice that were administered DEX and normal saline; however, the level of aspartate was increased drastically in Otc spf−ash mice owing to DEX administration ( P < 0.01). Among the enzymes associated with the urea cycle, mRNA expressions of carbamoyl-phosphate synthase 1, ornithine transcarbamylase, arginosuccinate synthase 1, and arginosuccinate lyase in the livers were significantly downregulated by DEX administration in both the Otc spf−ash and WT mice ( P < 0.01). Among the enzymes associated with catabolism, mRNA expression of Muscle RING-finger protein-1 in the muscles was significantly upregulated in the muscles of WT mice by DEX administration ( P < 0.05). Conclusions We elucidated that corticosteroid administration induced hyperammonemia in Otc spf−ash mice by not only muscle catabolism but also suppressing urea-cycle-related gene expressions. Since the urea cycle intermediate amino acids, such as arginine, might not be effective because of the suppressed expression of urea-cycle-related genes by corticosteroid administration, we should consider an early intervention by renal replacement therapy in cases of UCD patients induced by corticosteroids to avoid brain injuries or fatal outcomes.

Expression of Ornithine Transcarbamylase Deficiency in the Small Intestine and Colon of Sparse‐Fur Mutant Mice

Identification and Characterization of Mouse MTO1 Gene Related to Mitochondrial Trna Modification.

Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism

Restoring Ornithine Transcarbamylase (OTC) Activity in an OTC‐deficient Mouse Model Using LUNAR‐OTC Mrna

Lysine 88 Acetylation Negatively Regulates Ornithine Carbamoyltransferase Activity in Response to Nutrient Signals.

The functional impact of 1,570 individual amino acid substitutions in human OTC

Clinical and Molecular Characteristics of 69 Chinese Patients with Ornithine Transcarbamylase Deficiency

Functional Expression of Carnitine/Organic Cation Transporter 1 in Murine Choroid Plexus

Recapitulation of Skewed X-Inactivation in Female Ornithine Transcarbamylase-Deficient Primary Human Hepatocytes in the FRG Mouse: A Novel System for Developing Epigenetic Therapies

A Novel Mutation In Ornithine Transcarbamylase Gene Identified From A Chinese Child With Ornithine Transcarbamylase Deficiency

Characterization of Organic Anion-Transporting Polypeptide (oatp) 1a1 and 1a4 Null Mice Reveals Altered Transport Function and Urinary Metabolomic Profiles.

Dysfunction of Organic Anion Transporting Polypeptide 1a1 Alters Intestinal Bacteria and Bile Acid Metabolism in Mice

Characterization of Organic Anion Transporting Polypeptide 1B2-Null Mice: Essential Role in Hepatic Uptake/Toxicity of Phalloidin and Microcystin-LR

In-depth analysis of OTC A208T case induced by OTC gene mutation and research on the prediction and simulation of the impact on protein function

Variable disease manifestations and metabolic management within a single family affected by ornithine transcarbamylase deficiency

Glutaminase 2 knockdown reduces hyperammonemia and associated lethality of urea cycle disorder mouse model

Revisiting the Roles of Catalytic Residues in Human Ornithine Transcarbamylase

Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency

Urinary Uracil: A Useful Marker for Ornithine Transcarbamylase Deficiency in Affected Males.

Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency

Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency